COMMIT
2005
ClOpidogrel and Metoprolol in Myocardial Infarction Trial (Second Chinese Cardiac Study, CCS-2)
In 45,852 patients with acute myocardial infarction, clopidogrel added to aspirin reduced death, reinfarction, or stroke compared with placebo.
Result
- Absolute difference
- 0.9 points
- NNT
- 112
reduction9P = 0.002
Absolute difference and NNT are derived from the event rates.
Also reported: Adding clopidogrel to aspirin reduced and all-cause death 7.5% vs 8.1% (7% reduction, P=0.03) without excess major bleeding. Factorial metoprolol arm neutral and increased cardiogenic shock.
- Subtopic
- clopidogrel
- Design
- Randomised, double-blind, placebo-controlled RCT, 2×2 factorial
- Relevance
- Important: one of several pillars.
- Cited in
- ESC 2023 ACSACC/AHA 2025 ACS
- Source
- Chen ZM, et al. Lancet. 2005;366(9497):1607-21.doi 10.1016/S0140-6736(05)67660-X
Discussion & critique
Used no loading dose and only ~2 weeks of in-hospital treatment in a predominantly fibrinolytic-treated population. Established adding clopidogrel to aspirin as routine in acute MI, a foundation of dual antiplatelet therapy.